Skip to main content
Interview with the Innovators
Multiple Myeloma Education

Clinical Pathways in Multiple Myeloma

Videos - Interview with the Innovators
Laura Bobolts, PharmD, BCOP
Senior Vice President, Clinical Strategy and Growth
OncoHealth
Pompano Beach, FL
Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS
Director, Pharmacy Operations
Florida Cancer Specialists & Research Institute
Tampa, FL
Hakan Kaya, MD
Hematologic Oncologist and Senior Partner, Cancer Care Northwest
Director, Inland Northwest Myeloma/Lymphoma & Transplant Program
Clinical Professor, Elson S. Floyd College of Medicine, Washington State University
Clinical Professor of Medicine, University of Washington School of Medicine
Spokane, WA
Lisa Raff, PharmD, MSPharm, BCPS, BCOP
Vice President, Pharmacy Services
OneOncology
Nashville, TN
Yonatan Resnick, PharmD
Director, Pharmacy Clinical Services
New England Cancer Specialists
Scarborough, ME
In this sixth installment, Hakan Kaya, MD, Lisa Raff, PharmD, MSPharm, BCPS, BCOP, and Laura Bobolts, PharmD, BCOP, discuss the importance of clinical pathways in multiple myeloma treatment as well as their development.
Related Items
Improving Abemaciclib Tolerability: Insights From the TRADE Dose-Escalation Study
Jamie Carroll, APRN, CNP, MSN
Videos published on November 12, 2025 in Interview with the Innovators
Managing Abemaciclib Side Effects: Practical Tips for Improving Patient Care
Jamie Carroll, APRN, CNP, MSN
Videos published on November 10, 2025 in Interview with the Innovators
Managing Abemaciclib Toxicity: Proactive Strategies for Improved Patient Outcomes
Heather Moore, PharmD, BCOP, CPP
Videos published on November 5, 2025 in Interview with the Innovators
Insights From the TRADE Study: Optimizing Abemaciclib Dose Escalation for Better Tolerability and Adherence
Heather Moore, PharmD, BCOP, CPP
Videos published on November 3, 2025 in Interview with the Innovators
TRADE Study Insights: A New Approach to Improve Abemaciclib Tolerability in Breast Cancer Care
Erica Mayer, MD, MPH
Videos published on October 28, 2025 in Interview with the Innovators
Optimizing Adjuvant Abemaciclib: Insights From the TRADE Study on Dose Escalation and Tolerability
Erica Mayer, MD, MPH
Videos published on October 24, 2025 in Interview with the Innovators
Importance of Hospital Partnerships for Bispecific Agent Implementation
Laura Bobolts, PharmD, BCOP, Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS, Hakan Kaya, MD, Lisa Raff, PharmD, MSPharm, BCPS, BCOP, Yonatan Resnick, PharmD
Videos published on March 21, 2025 in Interview with the Innovators
EHR Implementation of Bispecific Agents for Multiple Myeloma
Laura Bobolts, PharmD, BCOP, Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS, Hakan Kaya, MD, Lisa Raff, PharmD, MSPharm, BCPS, BCOP, Yonatan Resnick, PharmD
Videos published on March 13, 2025 in Interview with the Innovators
Total Cost of Care for Bispecific Agents in Multiple Myeloma
Laura Bobolts, PharmD, BCOP, Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS, Hakan Kaya, MD, Lisa Raff, PharmD, MSPharm, BCPS, BCOP, Yonatan Resnick, PharmD
Videos published on March 10, 2025 in Interview with the Innovators
Payer Policy Development for Bispecific Agents in Multiple Myeloma
Laura Bobolts, PharmD, BCOP, Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS, Hakan Kaya, MD, Lisa Raff, PharmD, MSPharm, BCPS, BCOP, Yonatan Resnick, PharmD
Videos published on February 19, 2025 in Interview with the Innovators